Lopedium, 2 mg capsules 10 pcs

Pharmgroup:

Antidiarrheal agent.

Pharmic action:

Lopedium is an antidiarrheal symptomatic drug.

Binding to opioid receptors of the intestinal wall, loperamide reduces tone and motility of intestinal smooth muscle. Slows down peristalsis and increases the time of passage of intestinal contents. Increases the tone of the anal sphincter. Helps to retain feces and reduce the urge to defecation.

The action comes quickly and lasts for 4-6 hours.

Indications

Symptomatic treatment of acute and chronic diarrhea of ​​various origins (allergic, emotional, medicinal, radiation;
when changing the diet and quality of food, when metabolism and absorption are impaired;
as an adjuvant for diarrhea of ​​infectious origin).

Regulation of bowel movements in patients with ileostomy.

Pharmacological effect

Pharmaceutical group:

antidiarrheal agent.

Pharmaceutical action:

Lopedium is a symptomatic antidiarrheal drug.

By binding to opioid receptors in the intestinal wall, loperamide reduces the tone and motility of intestinal smooth muscles. Slows down peristalsis and increases the transit time of intestinal contents. Increases the tone of the anal sphincter. Helps retain feces and reduce the urge to defecate.

The action occurs quickly and lasts for 4-6 hours.

Special instructions

If there is no effect after 2 days of using the drug Lopedium, it is necessary to clarify the diagnosis and exclude the infectious genesis of diarrhea.

If constipation or bloating develops during treatment, the drug should be discontinued.

In patients with impaired liver function, careful monitoring for signs of toxic damage to the central nervous system is necessary.

During the treatment period, it is necessary to replenish the loss of fluid and electrolytes.

Each tablet or capsule of the drug Lopedium corresponds to 0.01 XE.

Impact on the ability to drive vehicles and operate machinery

If drowsiness or dizziness occurs, you should refrain from driving vehicles or operating machinery.

Active ingredient

Loperamide

Composition

Active ingredient:

loperamide hydrochloride 2 mg;

Excipients:

lactose monohydrate;

corn starch;

talc;

magnesium stearate

Contraindications

Hypersensitivity to the drug, diverticulosis, intestinal obstruction, ulcerative colitis in the acute stage, diarrhea against the background of acute pseudomembranous enterocolitis;
as monotherapy – dysentery and other gastrointestinal infections;
pregnancy (first trimester), lactation period;
children under 6 years old.

With caution: liver failure.

Side Effects

Headache; gastralgia, dry mouth, allergic reactions (skin rash), drowsiness or insomnia, dizziness, intestinal colic, nausea, vomiting, constipation.

Extremely rare – intestinal obstruction.

Overdose

Symptoms: depression of the central nervous system (stupor, loss of coordination, drowsiness, miosis, muscle hypertonicity, respiratory depression), intestinal obstruction.

Treatment: antidote – naloxone; Given that the duration of action of loperamide is longer than that of naloxone, repeated administration of the latter is possible.

Symptomatic treatment: activated carbon, gastric lavage, artificial ventilation.
Medical supervision is required for at least 48 hours.

Storage conditions

At a temperature not exceeding 25 °C.

Shelf life

5 years

Manufacturer

Salutas Pharma GmbH, Germany